Literature DB >> 26155039

Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.

Narendra S Choudhary1, Neeraj Saraf1, Sanjiv Saigal1, Dheeraj Gautam2, Lipika Lipi2, Amit Rastogi1, Sanjay Goja1, Palat B Menon1, Prashant Bhangui1, Sumana K Ramchandra1, Arvinder S Soin1.   

Abstract

BACKGROUND: Liver steatosis is the leading cause of donor rejection in living donor liver transplantation. Rapid weight loss is difficult to achieve in a short period of time, moreover it has been thought to worsen liver histology.
METHODS: Donors who had significant steatosis based on liver biopsy were recommended 1200 Kcal/day and a minimum of 60 min/day moderate cardio training. Two patients were advised statins for dyslipidemia. None of the donors had metabolic syndrome. A second ultrasound guided liver biopsy was done at 28 ± 10 days. Donors with nonalcoholic steatohepatitis/fibrosis or >30% steatosis were not included.
RESULTS: From July 2010 to January 2015, 16 donors were advised aggressive life style modification after initial biopsy; 15 (10 males, age 27.5 ± 6.5 years, baseline body mass index 28.4 ± 2.1 Kg/M(2)) successfully reduced weight and 14 underwent donation after favorable second biopsy. Mean weight loss was 7 ± 4.3 kg (8.4 ± 4.6%). Second liver biopsy was done at 28 ± 10 days, there was decrease in steatosis in all but one including normalization of liver biopsy in 7 donors. Three donors had mild inflammation on first biopsy and they had improvement in second biopsy. All the donors and their recipients had an uneventful post-operative course.
CONCLUSION: Steatosis can be reversed in a short duration by aggressive life style modifications in highly motivated liver donors.

Entities:  

Keywords:  ALT, alanine transaminase; ALT, aspartate transaminase; BMI, body mass index; LAI, liver attenuation index; LDLT, living donor liver transplantation; NAFLD, non-alcoholic fatty liver disease; diet; donor; exercise; life style modification; liver biopsy

Year:  2015        PMID: 26155039      PMCID: PMC4491642          DOI: 10.1016/j.jceh.2015.04.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  13 in total

1.  Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Jau-Chung Hwang; Hung Chiang; Chi-Yang Chang; Ching-Tai Lee; Ming-Lung Yu; Jaw-Town Lin
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.

Authors:  Carlos K Furuya; Claudia P M S de Oliveira; Evandro S de Mello; Joel Faintuch; Alessandra Raskovski; Mitsunori Matsuda; Denise C P Vezozzo; Alfredo Halpern; Arthur B Garrido; Venâncio A F Alves; Flair J Carrilho
Journal:  J Gastroenterol Hepatol       Date:  2007-04       Impact factor: 4.029

3.  Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.

Authors:  Samer G Mattar; Laura M Velcu; Mordechai Rabinovitz; A J Demetris; A M Krasinskas; Emma Barinas-Mitchell; George M Eid; Ramesh Ramanathan; Debra S Taylor; Philip R Schauer
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

4.  Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.

Authors:  F H Luyckx; C Desaive; A Thiry; W Dewé; A J Scheen; J E Gielen; P J Lefèbvre
Journal:  Int J Obes Relat Metab Disord       Date:  1998-03

Review 5.  Effects of weight loss on nonalcoholic fatty liver disease.

Authors:  Nila Rafiq; Zobair M Younossi
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

6.  Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Jeanne M Clark; Amir R A Alkhuraishi; Steven F Solga; Patricia Alli; Anna Mae Diehl; Thomas H Magnuson
Journal:  Obes Res       Date:  2005-07

7.  Regression of hepatic steatosis in morbidly obese persons after gastric bypass.

Authors:  E M Silverman; J A Sapala; H D Appelman
Journal:  Am J Clin Pathol       Date:  1995-07       Impact factor: 2.493

8.  Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.

Authors:  John B Dixon; Prithi S Bhathal; Norman R Hughes; Paul E O'Brien
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

9.  Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.

Authors:  Piyaporn Limanond; Steven S Raman; Charles Lassman; James Sayre; R Mark Ghobrial; Ronald W Busuttil; Sammy Saab; David S K Lu
Journal:  Radiology       Date:  2004-01       Impact factor: 11.105

10.  Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Authors:  Xiuli Liu; Audrey J Lazenby; Ronald H Clements; Nirag Jhala; Gary A Abrams
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

View more
  10 in total

1.  Liver sympathetic denervation reverses obesity-induced hepatic steatosis.

Authors:  Chansol Hurr; Hayk Simonyan; Donald A Morgan; Kamal Rahmouni; Colin N Young
Journal:  J Physiol       Date:  2019-07-26       Impact factor: 5.182

Review 2.  Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death.

Authors:  Shen-Ping Tang; Xin-Li Mao; Ya-Hong Chen; Ling-Ling Yan; Li-Ping Ye; Shao-Wei Li
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 3.  Non-alcoholic fatty liver disease and diabetes.

Authors:  Jonathan M Hazlehurst; Conor Woods; Thomas Marjot; Jeremy F Cobbold; Jeremy W Tomlinson
Journal:  Metabolism       Date:  2016-01-11       Impact factor: 8.694

4.  Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis.

Authors:  Rahul Sao; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-05       Impact factor: 3.318

Review 5.  Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved.

Authors:  D Osipova; K Kokoreva; L Lazebnik; E Golovanova; Ch Pavlov; A Dukhanin; S Orlova; K Starostin
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

6.  Lose Weight to Donate: Development of a Program to Optimize Potential Donors With Hepatic Steatosis or Obesity for Living Liver Donation.

Authors:  John T Rose; Paola Vargas; Tara Seay; Arthur J Pesch; Tessa Williams; Anita Sites; Zachary Henry; Patrick G Northup; Shawn J Pelletier; Jose Oberholzer; Curtis K Argo; Nicolas Goldaracena
Journal:  Transplant Direct       Date:  2021-05-25

7.  Weight loss interventions in living donor liver transplantation as a tool in expanding the donor pool: A systematic review and meta-analysis.

Authors:  Sushrut Trakroo; Nakul Bhardwaj; Rajat Garg; Jamak Modaresi Esfeh
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

Review 8.  Feasibility of using marginal liver grafts in living donor liver transplantation.

Authors:  Xiang Lan; Hua Zhang; Hong-Yu Li; Ke-Fei Chen; Fei Liu; Yong-Gang Wei; Bo Li
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742

9.  Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation.

Authors:  Jae Hun Chung; Je Ho Ryu; Kwang Ho Yang; Byung Hyun Choi; Youngmok Park; Tae Beom Lee; Jae Ryong Shim; Hyo Jung Ko; Sung Hwan Cho
Journal:  Ann Transplant       Date:  2020-07-21       Impact factor: 1.530

Review 10.  Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights.

Authors:  Paola Berenice Mass Sanchez; Marinela Krizanac; Ralf Weiskirchen; Anastasia Asimakopoulos
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.